Cancer Cell is a peer-reviewed scientific journal published by Cell Press. It focuses on all aspects of cancer research at the cellular-level. The journal was established in February 2002, and is edited by Li-Kuo Su.
A study led by researchers at the UCLA Jonsson Comprehensive Cancer Center has found that targeting a metabolic process in people with a specific genetic mutation could help treat glioblastoma, an aggressive brain cancer.
May 25, 2023
0
37
Up to 60% of cancer patients receive radiation therapy, but it doesn't always work. Failure of these treatments results from tumor regrowth at the primary tumor site, or when the tumor metastasizes to another part of the ...
May 25, 2023
0
57
Every year, approximately 400 women die of ovarian cancer in Finland, while the corresponding figure for Europe overall is more than 40,000. Ovarian cancer is a genetically very heterogeneous disease, which makes it exceptionally ...
May 19, 2023
0
12
Researchers from Uppsala University have developed a method that helps immune cells exit from blood vessels into a tumor to kill cancer cells. The goal is to improve treatment of aggressive brain tumors. The study has been ...
May 12, 2023
0
386
An international team of researchers led by the Netherlands Cancer Institute developed a method to better predict the outgrowth of ductal carcinoma in situ (DCIS), a possible precursor of breast cancer, into invasive breast ...
May 3, 2023
0
46
A unique treatment combining radiation and immunotherapy can eradicate pancreatic tumors while stopping the cancer from spreading, according to a new study by researchers at the University of Colorado Cancer Center.
Apr 27, 2023
0
80
Understanding the differences in the evolution of lung cancer between smokers and non-smokers could be the key to unlocking new treatments.
Apr 20, 2023
0
30
Over the decades, scientists have revealed many strategies our cells use to keep normal cells from becoming cancerous. Now, Fred Hutchinson Cancer Center scientists have discovered a completely new—and counterintuitive—emergency ...
Apr 20, 2023
0
61
Research led by scientists at UCLA Jonsson Comprehensive Cancer Center found that responses to a type of immunotherapy called PD-1 checkpoint blockade in patients with advanced melanoma depended on whether or not they had ...
Apr 10, 2023
0
5
A team of Harvard and Sloan Kettering scientists has developed compounds that can target and degrade proteins associated with acute myeloid leukemia (AML) and nearly doubled the life expectancy of mice with cancer in laboratory ...
Apr 3, 2023
0
74
